Category: oixepzyh

CITY MOVES | WHO’S SWITCHING JOBS

first_imgThursday 27 January 2011 7:20 pm CITY MOVES | WHO’S SWITCHING JOBS whatsapp Tags: NULL Share Show Comments ▼ KCS-content Read This Next’A Quiet Place Part II’ Sets Pandemic Record in Debut WeekendFamily ProofHiking Gadgets: Amazon Deals Perfect For Your Next AdventureFamily ProofAmazon roars for MGM’s lion, paying $8.45 billion for studio behind JamesFamily ProofIndian Spiced Vegetable Nuggets: Recipes Worth CookingFamily ProofYoga for Beginners: 3 Different Types of Yoga You Should TryFamily ProofBack on the Rails for Summer New York to New Orleans, Savannah and MiamiFamily ProofChicken Bao: Delicious Recipes Worth CookingFamily ProofNew England Patriots’ Cam Newton says no extra motivation from Mac Jones’SportsnautCheese Crostini: Delicious Recipes Worth CookingFamily Proof ShireGlobal speciality biopharmaceutical company Shire has hired Emmanuel Chantelot, former executive director of the European Biopharmaceutical Enterprises (EBE), as director of European government relations and public policy. Chantelot brings 18 years of experience in policy advocacy, strategic communications and business interest representation towards the EU Institutions, global agencies and national governments.JP MorganJohn Pietri has been hired as an executive director and senior banker for its private banking team in France, based in Paris. Prior to joining JP Morgan, Pietri was with Société Générale’s corporate and investment banking business for thirteen years where he was a director in the M&A team in Paris. Prior to that, he was a manager at Bossard Consultants for five years.FFastFillFFastFill, the leading provider of software as a service to the global derivatives community, has appointed Mark Carlisle as finance chief for the group. Carlisle joins FFastFill from Kewill where he has worked since March 2010 as group controller. He will take up his position in April 2011 and will concurrently join the FFastFill board of directors. Carlisle qualified as a chartered accountant in 2003, and began his career at Deloitte, where he was a senior manager within the firm’s technology, media and telecommunications audit practice.KPMGKPMG has appointed Graham Martin and Stuart King to head up its new portfolio solutions group service offering, within its transactions and restructuring practice. Martin and King will be leading a broader team of eight; made up of four directors, three senior managers and one manager, all from PwC. KPMG’s financial services transactions and restructuring team, brings together M&A, valuation, due diligence, tax and distressed debt specialists. The team is based in the UK, Spain, Germany, Thailand and the US.RobecoThe investment products and services provider has appointed Jurgen Stegmann as chief financial officer. Stegmann was previously vice-chairman of the managing board and chief risk officer at NIBC in The Hague. whatsapplast_img read more

First National Bank of Botswana Limited (FNBB.bw) 2010 Abridged Report

first_imgFirst National Bank of Botswana Limited (FNBB.bw) listed on the Botswana Stock Exchange under the Banking sector has released it’s 2010 abridged results.For more information about First National Bank of Botswana Limited (FNBB.bw) reports, abridged reports, interim earnings results and earnings presentations, visit the First National Bank of Botswana Limited (FNBB.bw) company page on AfricanFinancials.Document: First National Bank of Botswana Limited (FNBB.bw)  2010 abridged results.Company ProfileFirst National Bank of Botswana Limited is a financial services institution providing products and solutions for personal, business and private clients in Botswana. Its personal banking division offers the standard range of transaction products as well as student accounts, overdrafts and loans and online banking products. The business banking division offers additional services such as purchase order finance, premium credit facilities and commercial property loans. First National Bank of Botswana also provides agricultural solutions, farming enterprise finance, business investment solutions and farm risk insurance finance along with solutions for payments, funding, cash management services to the public sector, and treasury and trade services. The private banking division offers wealth and advisory services, and structured lending services. The banking group facilitates its banking services through the Pick n Pay franchise with a sales and service channel called FNBB Kiosk. First National Bank of Botswana Limited is a subsidiary of First National Bank Holdings (Botswana) Limited.last_img read more

Royal Swaziland Sugar Corporation (RSSC.sz) 2012 Abridged Report

first_imgRoyal Swaziland Sugar Corporation (RSSC.sz) listed on the Swaziland Stock Exchange under the Food sector has released it’s 2012 abridged results.For more information about Royal Swaziland Sugar Corporation (RSSC.sz) reports, abridged reports, interim earnings results and earnings presentations, visit the Royal Swaziland Sugar Corporation (RSSC.sz) company page on AfricanFinancials.Document: Royal Swaziland Sugar Corporation (RSSC.sz)  2012 abridged results.Company ProfileRoyal Swaziland Sugar Corporation (RSSC) Limited is the largest company in Swaziland with interests in sugar cane farming and manufacturing refined sugar products and ethanol for regional consumption and import to the rest of Africa and Europe. RSSC produces beverage-grade ethanol that is used in alcoholic beverages as well as pharmaceuticals and water treatment products. The company produces feints used to manufacture methylated spirits and bio gels. It also produces compressed molasses stillage used to produce liquid fertilisers. RSSC manages approximately 15 600 hectares of irrigated sugar cane on two estates leased from the Swazi Nation and manages an additional 5 000 hectares of half of third parties. It has capacity to produce 2.3 million tonnes of cane per season and about 430 000 tonnes of raw sugar per season. RSSC is a subsidiary of Tibiyo Taka Ngwane with headquarters in Simunye, Swaziland. Royal Swaziland Sugar Corporation is listed on the Swaziland Stock Exchangelast_img read more

O2 Inside Line – Season 4 Episode 5

first_imgWednesday Feb 5, 2014 O2 Inside Line – Season 4 Episode 5 England took heart from their narrow loss to France last weekend and have been in camp preparing for Scotland and the Calcutta Cup. Hosted by the brilliant Alex Payne, this latest episode of O2 Inside Line gives superb insight and build up for the match. Despite the loss to the French at the weekend, England have kept faith in the same starting XV for this Saturday’s Murrayfield clash with Scotland.“It’s good to be able to select the same players and they are all determined to put last week’s result behind us and build on the performance,” said head coach Stuart Lancaster.“Scotland will be hugely motivated by their defeat in Dublin and, as we found two years ago, Murrayfield is a tough place to play,” he added.England have won the last four Calcutta Match encounters but will be wary of a Scotland team that contain the likes of Stuart Hogg, who is always willing to attack from deep. In this week’s O2 Inside Line Player Analysis features Hogg himself, as they look at ways to cut down his space.There’s also a look back at a great bit of play by Billy Vunipola, and then Player Cam gives us a look into a gym session, where Brad Barritt casually bench presses roughly 120kg’s.There is good banter between the players when they talk about who would play them in a film, and then we learn about the Head of Stadium Events for the RFU, Nigel Cox, and what his role involves.Kickoff at Murrayfield on Saturday is at 5pm (local)England team:Mike Brown, Jack Nowell, Luther Burrell, Billy Twelvetrees, Jonny May, Owen Farrell,  Danny Care, Joe Marler, Dylan Hartley, Dan Cole, Joe Launchbury, Courtney Lawes, Tom Wood, Chris Robshaw, Billy Vunipola Replacements: Tom Youngs, Mako Vunipola, Henry Thomas, Dave Attwood, Ben Morgan, Lee Dickson, Brad Barritt, Alex GoodeScotland team: Stuart Hogg, Tommy Seymour, Alex Dunbar, Matt Scott, Sean Lamont, Duncan Weir, Greig Laidlaw, Ryan Grant, Ross Ford, Moray Low, Tim Swinson, Jim Hamilton, Ryan Wilson, Chris Fusaro, David Denton Replacements: Scott Lawson, Alasdair Dickinson, Geoff Cross, Jonny Gray, Johnnie Beattie, Chris Cusiter, Duncan Taylor, Max EvansADVERTISEMENT Posted By: rugbydump Share Send Thanks Sorry there has been an error O2 Inside Line Related Articles 377 WEEKS AGO O2 Inside Line – Season 4 Episode 9 – England… 378 WEEKS AGO O2 Inside Line – Season 4 Episode 8 379 WEEKS AGO O2 Inside Line – Season 4 Episode 7 From the WebThis Video Will Soon Be Banned. Watch Before It’s DeletedSecrets RevealedUrologists Stunned: Forget the Blue Pill, This “Fixes” Your EDSmart Life ReportsYou Won’t Believe What the World’s Most Beautiful Girl Looks Like TodayNueeyGranny Stuns Doctors by Removing Her Wrinkles with This Inexpensive TipSmart Life ReportsIf You Have Ringing Ears Do This Immediately (Ends Tinnitus)Healthier Living10 Types of Women You Should Never MarryNueeyThe content you see here is paid for by the advertiser or content provider whose link you click on, and is recommended to you by Revcontent. As the leading platform for native advertising and content recommendation, Revcontent uses interest based targeting to select content that we think will be of particular interest to you. We encourage you to view your opt out options in Revcontent’s Privacy PolicyWant your content to appear on sites like this?Increase Your Engagement Now!Want to report this publisher’s content as misinformation?Submit a ReportGot it, thanks!Remove Content Link?Please choose a reason below:Fake NewsMisleadingNot InterestedOffensiveRepetitiveSubmitCancellast_img read more

Threat to local broadcasts by foreign radio stations

first_img Help by sharing this information Follow the news on Azerbaijan AzerbaijanEurope – Central Asia Reporters Without Borders condemns the government’s threat to stop foreign radio stations from broadcasting on local frequencies from the start of next month under a law requiring them to sign a contract with the Azerbaijani authorities in order to be able to continue. The Azeri-language programmes of Radio Free Europe/ Radio Liberty, BBC and Voice of America are the most likely to be affected.“The threat to these radio stations completely contradicts the commitments Azerbaijan gave when it joined the Organisation for Security and Cooperation in Europe (OSCE) and the Council of Europe,” Reporters Without Borders said. “We call for the maintenance of foreign news broadcasts in Azerbaijan. If the solution is signing a contract with the state, we hope this will be possible. It if is not, it will clearly have been a political decision.”Azerbaijan undertook to democratise itself when it joined the OSCE in 1992 and the Council of Europe in 2001. Local broadcasting by RFE/RL, BBC and Voice of America has been under threat since last summer. The National TV and Radio Council is due to reach a final decision on 25 December. If it allows them to continue broadcasting, it is expected to request content changes. RSF_en “We’ll hold Ilham Aliyev personally responsible if anything happens to this blogger in France” RSF says AzerbaijanEurope – Central Asia Receive email alerts Russian peacekeepers deny foreign reporters access to Nagorno-Karabakh News Newscenter_img News News RSF calls for a fully transparent investigation after mine kills two journalists in Azerbaijan June 4, 2021 Find out more to go further December 22, 2008 – Updated on January 20, 2016 Threat to local broadcasts by foreign radio stations June 8, 2021 Find out more Organisation April 9, 2021 Find out morelast_img read more

Tamil journalist gunned down in Trincomalee after covering paramilitary abuses

first_img News Sri Lanka: tamil reporter held on absurd terrorism charge Receive email alerts RSF_en Reporters Without Borders condemns the murder today of Subramaniyam Sugirdharajan, a correspondent of the Tamil-language daily Sudar Oli in the eastern city of Trincomalee, and calls on Prime Minister Ratnasiri Wickremanayake to do everything possible to ensure that both the perpetrators and instigators are identified and arrested. Sri LankaAsia – Pacific Sri Lanka: RSF signs joint statement on attacks against human rights defenders, lawyers and journalists Organisation January 13, 2021 Find out more News Follow the news on Sri Lanka to go further Reporters Without Borders today condemned the murder of Subramaniyam Sugirdharajan, a correspondent of the Tamil-language daily Sudar Oli in the eastern city of Trincomalee, who was gunned down early this morning after writing yesterday about the abuses committed in his region by Tamil paramilitary groups.“We are horrified by the level of violence against Tamil journalists,” the press freedom organisation said. “The impunity enjoyed by the instigators and perpetrators of these murders encourages more violence against the press. We urge Prime Minister Ratnasiri Wickremanayake to do everything possible to ensure that the police identify and arrest Sugirdharajan’s murderers, as well as the murderers of Relangi Sevaraja and Dharmeratnam Sivaram, who are still at large.”Sugirdharajan is the third Tamil journalist to have been killed in the past 12 months. Ten others have been arrested, physically attacked or threatened by the security forces or the Tamil armed movements.Aged 35 and the father of two small children, Sugirdharajan was a Trincomalee port employee as well as a journalist. He was shot dead at about 6 a.m. today as he was waiting for public transport to go to work. His killers used a motor-cycle to get away after shooting him. Police went to the scene of the murder. According to the Tamilnet website, he was gunned down near the governor’s secretariat.In an article for yesterday’s issue of Sudar Oli, he detailed the abuses committed by Tamil paramilitary groups including the EPDP in the Trincomalee region. The newspaper also recently ran photos taken by Sugirdharajan showing that five Trincomalee students were shot dead at point-blank range on 2 January, disproving the army’s claim that they were killed by a grenade explosion.Sudar Oli, which tends to support the Tamil Tigers (LTTE), was attacked and threatened several times last year. Two grenades were thrown at the office of its advertising department on 20 August but did not explode. Three days later, a staff journalist was roughed up and detained by the police on suspicion of being an LTTE spy. A security guard, David Selvaratnum, was killed in a grenade attack outside the newspaper’s office in Colombo on 29 August. Sudar Oli belongs to the Jaffna-based press group Uthayan, which has also been the target of attacks. Sri LankaAsia – Pacific Help by sharing this information News July 29, 2020 Find out more News Sri Lanka: Journalist manhandled by notorious police inspector currently on trial January 24, 2006 – Updated on January 20, 2016 Tamil journalist gunned down in Trincomalee after covering paramilitary abuses July 15, 2020 Find out morelast_img read more

Harbor Foils Men’s Basketball, 66-61

first_img More Cool Stuff Subscribe Business News Make a comment First Heatwave Expected Next Week 3 recommended0 commentsShareShareTweetSharePin it Sports Harbor Foils Men’s Basketball, 66-61 By ROBERT LEWIS Published on Monday, January 26, 2015 | 11:10 am Pasadena Will Allow Vaccinated People to Go Without Masks in Most Settings Starting on Tuesday Pasadena’s ‘626 Day’ Aims to Celebrate City, Boost Local Economy Herbeauty8 Easy Exotic Meals Anyone Can MakeHerbeautyHerbeautyHerbeautyTop Important Things You Never Knew About MicrobladingHerbeautyHerbeautyHerbeautyShort On Time? 10-Minute Workouts Are Just What You NeedHerbeautyHerbeautyHerbeauty10 Special Massage Techniques That Will Make You Return For MoreHerbeautyHerbeautyHerbeautyWhat’s Your Zodiac Flower Sign?HerbeautyHerbeautyHerbeautyThe Most Heartwarming Moments Between Father And DaughterHerbeautyHerbeauty EVENTS & ENTERTAINMENT | FOOD & DRINK | THE ARTS | REAL ESTATE | HOME & GARDEN | WELLNESS | SOCIAL SCENE | GETAWAYS | PARENTS & KIDScenter_img Community News Name (required)  Mail (required) (not be published)  Website  Your email address will not be published. Required fields are marked * Top of the News Home of the Week: Unique Pasadena Home Located on Madeline Drive, Pasadena Get our daily Pasadena newspaper in your email box. Free.Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m. faithfernandez More » ShareTweetShare on Google+Pin on PinterestSend with WhatsApp,Virtual Schools PasadenaHomes Solve Community/Gov/Pub SafetyCitizen Service CenterPASADENA EVENTS & ACTIVITIES CALENDARClick here for Movie Showtimes Jonathan Henderson in action in a recent home game.Close but no cigar has become a frustrating reality for the 2014-15 Pasadena City College men’s basketball team. Since the new year, only a 14 combined points difference has led to four losses and a 2-4 record that has dropped the Lancers to 8-12 overall.In a non-conference game Friday night, PCC nearly erased a 13-point second-half deficit but host Los Angeles Harbor hung on for a 66-61 win. The Lancers were down 61-48 with three minutes left, but fought back with eight consecutive points in a little more than a minute span. The rally was capped by letterman center Faruk Oyalade’s put-back basket.But luck hasn’t been on the Lancers’ side as case evidence their next trip down the floor. PCC’s pressure defense forced a turnover and the Lancers almost dropped the lead to two, but a 3-point attempt by freshman guard Demetrius Overstreet rimmed in-and-out. Harbor followed with two free throws by Elliot Morris that put the game out of reach, 63-56, with 1:16 remaining.Sophomore guard Jonathan Henderson led PCC with 19 points, including four 3-point baskets, while frosh guard Dejon Williams had 12 points and four assists. Off the bench center Donell Tuff added nine points and 10 rebounds. Starting center Faruk Oyalade compiled six points and 13 rebounds.Morris scored 19 points to pace Harbor (11-7).Pasadena will host El Camino College on Wednesday, Jan. 28 in a 5 p.m. tip-off at Hutto-Patterson Gymnasium. Community Newslast_img read more

HERTHENA-Lung01 Phase 2 Study of Daiichi Sankyo’s Patritumab Deruxtecan Initiated in Patients with EGFR-Mutated…

first_img Twitter HERTHENA-Lung01 Phase 2 Study of Daiichi Sankyo’s Patritumab Deruxtecan Initiated in Patients with EGFR-Mutated NSCLC Twitter TAGS  By Digital AIM Web Support – February 3, 2021 Previous articleRidge Security Penetration Testing Solution Hardens Networks With Expanded Ransomware ProtectionNext articleInventory Management Software Market Procurement Intelligence Report With COVID-19 Impact Analysis | Global Forecasts, 2021-2025 Digital AIM Web Support Pinterest WhatsAppcenter_img Facebook Pinterest Facebook WhatsApp Local NewsBusiness TOKYO & BASKING RIDGE, N.J. & MUNICH–(BUSINESS WIRE)–Feb 3, 2021– Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the first patient has been dosed in HERTHENA-Lung01, a phase 2 study evaluating patritumab deruxtecan, a HER3 directed DXd antibody drug conjugate (ADC), in patients with epidermal growth factor receptor (EGFR)-mutated metastatic or locally advanced non-small cell lung cancer (NSCLC) previously treated with a tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy. Lung cancer is the leading cause of cancer death among both men and women, and accounts for about one-fifth of all cancer deaths globally, with 80 to 85 percent classified as NSCLC. 1,2 For patients with metastatic disease, prognosis is particularly poor, as only 6 to 10 percent live beyond five years after diagnosis. 3 Approximately 25 to 30 percent of lung cancers worldwide have an EGFR-activating mutation, and it is estimated that about 83 percent of all NSCLC tumors express the HER3 protein, which can be associated with an increased incidence of metastases, reduced survival and resistance to standard of care treatment. 4,5,6 There currently are no HER3 directed medicines approved for the treatment of NSCLC. “Our focus is to rapidly and strategically advance the clinical development program of patritumab deruxtecan in cancers where HER3 is frequently overexpressed and is associated with poor prognosis,” said Gilles Gallant, BPharm, PhD, FOPQ, Senior Vice President, Global Head, Oncology Development, Oncology R&D, Daiichi Sankyo. “This study will further inform whether targeting HER3 with an antibody drug conjugate may become a potential treatment strategy to overcome diverse mechanisms of EGFR TKI and chemotherapy resistance seen in patients with metastatic EGFR-mutated non-small cell lung cancer.” Exploratory biomarker analyses from the ongoing phase 1 study of patritumab deruxtecan in patients with previously treated metastatic or locally advanced EGFR-mutated NSCLC were recently presented at the IASLC 2020 World Conference on Lung Cancer (WCLC), hosted by the International Association for the Study of Lung Cancer. Encore clinical results from this phase 1 study also were presented at WCLC. About HERTHENA-Lung01 HERTHENA-Lung01 is a global, multicenter, open-label, phase 2 study evaluating the safety and efficacy of patritumab deruxtecan in patients with locally advanced or metastatic NSCLC with an EGFR-activating mutation (exon 19 deletion or L858R) who have progressed after receiving at least one EGFR TKI and at least one platinum-based chemotherapy regimen. The study will randomize patients into one of two patritumab deruxtecan treatment arms in a 1:1 ratio. Patients in the first arm of the study will receive a 5.6 mg/kg fixed dose regimen of patritumab deruxtecan intravenously every three weeks. Patients in the second arm will receive an up-titration dose regimen of patritumab deruxtecan in three week cycles, with a 3.2 mg/kg dose given in the first cycle, a 4.8 mg/kg dose in the second, and 6.4 mg/kg in the third and subsequent cycles. The primary endpoint of HERTHENA-Lung01 is objective response rate (ORR), as assessed by blinded independent central review (BICR). Secondary endpoints include duration of response, progression-free survival, disease control rate, and time to response – all assessed by both BICR and investigator assessment – as well as investigator-assessed ORR, overall survival, safety and tolerability. The level of HER3 protein expression in tumor tissue and its relationship with efficacy will be analyzed. Pharmacokinetics and immunogenicity also will be assessed. HERTHENA-Lung01 is expected to enroll up to approximately 420 patients in the U.S., Europe and Asia, including Japan. For more information about the study, visit ClinicalTrials.gov. About Non-Small Cell Lung Cancer Lung cancer is the most common cancer and the leading cause of cancer mortality worldwide; there were an estimated 2.2 million new cases of lung cancer and 1.8 million deaths in 2020. 1 Most lung cancers are diagnosed at an advanced or metastatic stage. 2 Non-small cell lung cancer (NSCLC) accounts for 80 to 85 percent of all lung cancers. 7 The introduction of targeted therapies and checkpoint inhibitors in the past decade has improved the treatment landscape for patients with advanced or metastatic NSCLC; however, the prognosis is particularly poor among patients who have progressed after treatment with standard therapies. For those who are not eligible for current treatments, or whose cancer continues to progress, new therapeutic approaches are needed. 8 The mutationally-activated EGFR tyrosine kinase is a well-established oncogenic driver and molecular target for management of advanced stage NSCLC. 9 For patients with advanced EGFR-mutated NSCLC, targeted therapy with EGFR TKIs offer higher response rates and progression-free survival compared to chemotherapy. 8 However, most patients eventually develop resistance to these therapies, and standard treatment options are limited. 10 Clinical resistance to EGFR TKIs has been linked to multiple molecular mechanisms, and in many cases, the underlying mechanism of resistance remains unknown. 11,12,13 About HER3 HER3 is a member of the EGFR family of receptor tyrosine kinases, which are associated with aberrant cell proliferation and survival. 14 Approximately 25 to 30 percent of lung cancers worldwide have an EGFR-activating mutation, and it is estimated that about 83 percent of all NSCLC tumors express the HER3 protein, which can be associated with an increased incidence of metastases, reduced survival and resistance to standard of care treatment. 4,5,6 Currently, no HER3 directed medicines are approved for the treatment of cancer. About Patritumab Deruxtecan Patritumab deruxtecan (HER3-DXd, U3-1402) is one of three lead DXd antibody drug conjugates (ADC) in the oncology pipeline of Daiichi Sankyo. Designed using Daiichi Sankyo’s proprietary DXd ADC technology, patritumab deruxtecan is comprised of a human anti-HER3 antibody attached to a topoisomerase I inhibitor payload, an exatecan derivative, via a stable tetrapeptide-based cleavable linker. Patritumab deruxtecan is currently being evaluated in a comprehensive development program across multiple cancers as both a monotherapy and in combination with other anticancer treatments. The development program includes HERTHENA-Lung01, a phase 2 study in patients with EGFR-mutated metastatic or locally advanced NSCLC previously treated with a TKI and platinum-based chemotherapy; a phase 2 study in patients with advanced/metastatic colorectal cancer with progression following at least two prior lines of systemic therapy; a phase 1/2 study in HER3 expressing metastatic breast cancer; a phase 1 study in combination with osimertinib in locally advanced/metastatic EGFR-mutated NSCLC; and, a phase 1 study in previously treated patients with metastatic or unresectable NSCLC. Patritumab deruxtecan is an investigational agent that has not been approved for any indication in any country. Safety and efficacy have not been established. About Daiichi Sankyo Cancer Enterprise The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA. For more information, please visit: www.DSCancerEnterprise.com. About Daiichi Sankyo Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. For more information, please visit: www.daiichisankyo.com. ———————————————————— References: 1 World Health Organization. GLOBOCAN 2020. Lung Cancer Fact Sheet. January 2021. 2 American Cancer Society. About Lung Cancer. Types of Lung Cancer. January 2020. 3 Goldstraw P, et al. J Thorac Oncol. 2016; 11(1):39–51. 4 Zhang YL, et al. Oncotarget. Vol. 7 No 49. 78985-78993. 5 Muller-Tidow C, et al. Cancer Res. 2005;65:1778-1772. 6 Scharpenseel, et al. Scientific Reports. 2019;9:7406. 7 American Cancer Society. Types of Non-Small Cell Lung Cancer. 2019. 8 Economopoulou P, et al. Ann Transl Med. 2018;6(8):138. 9 Planchard D, et al. Ann Oncol. 2018;29(4):iv192–237. Updated Sept. 2019. 10 Morgillo F, et al. ESMO Open. 2016;1:e000060. 11 Wu, et al. Mol Cancer. 2018;17:38. 12 Papadimitrakopoulou, et al. Ann Oncol. 2018;29(8). 13 Remon J, et al. Ann Oncol. 2018;29(1):i20–i27. 14 Mishra R, et al. Oncol Rev. 2018;12:355. View source version on businesswire.com:https://www.businesswire.com/news/home/20210203005120/en/ CONTACT: Media Contacts:Global/US: Jennifer Brennan Daiichi Sankyo, Inc. [email protected] + 1 908 992 6631 (office) +1 908 900 3183 (mobile)EU: Lydia Worms Daiichi Sankyo Europe GmbH [email protected] +49 (89) 7808751 (office) +49 176 11780861 (mobile)Japan: Masashi Kawase Daiichi Sankyo Co., Ltd. [email protected] +81 3 6225 1126 (office)Investor Relations Contact: [email protected] KEYWORD: UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC EUROPE GERMANY NEW JERSEY INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY SOURCE: Daiichi Sankyo Company, Limited Copyright Business Wire 2021. PUB: 02/03/2021 08:00 AM/DISC: 02/03/2021 08:01 AM http://www.businesswire.com/news/home/20210203005120/enlast_img read more

Lockdown Restrictions Applicable To Political Parties & Associations Also: Kerala HC [Read Order]

first_imgNews UpdatesLockdown Restrictions Applicable To Political Parties & Associations Also: Kerala HC [Read Order] Akshita Saxena14 July 2020 9:33 PMShare This – xA Chief Justice led division bench of the Kerala High Court has clarified that the directives issued by the Centre and the State Governments restricting social gatherings in view of the Covid-19 pandemic, are equally applicable to political parties and associations. Therefore, it held that the political parties should not hold dharna, processions, demonstrations, etc. as such gatherings…Your free access to Live Law has expiredTo read the article, get a premium account.Your Subscription Supports Independent JournalismSubscription starts from ₹ 599+GST (For 6 Months)View PlansPremium account gives you:Unlimited access to Live Law Archives, Weekly/Monthly Digest, Exclusive Notifications, Comments.Reading experience of Ad Free Version, Petition Copies, Judgement/Order Copies.Subscribe NowAlready a subscriber?LoginA Chief Justice led division bench of the Kerala High Court has clarified that the directives issued by the Centre and the State Governments restricting social gatherings in view of the Covid-19 pandemic, are equally applicable to political parties and associations. Therefore, it held that the political parties should not hold dharna, processions, demonstrations, etc. as such gatherings are also likely to be infected with the disease. The direction has come in a writ petition seeking de-recognition of certain political parties in the state of Kerala, for violating the lockdown restrictions and conducting dharna, processions, demonstrations, etc., thus increasing the risk of more positive Covid cases. “Reading of the directives issued by the Central as well as the State Governments make it clear that the guidelines are intended to be strictly adhered to by all the citizens, political parties and associations, the violation of which is punishable,” the bench of Chief Justice S Manikumar and Justice Shaji P Chaly held. The bench further held that the guidelines issued by the Supreme Court in In Re: Guidelinesfor Court Functioning Through Video Conferencing During COVID-19 Pandemic, as well as in Kodungallur Film Society& Anr. v. Union of India & Ors., are “binding” on all political parties. In the former case, the Top Court has had stressed upon the need for “physical distancing” while setting out modalities for video conferencing in all courts. In the latter case, the Court had set out the pre-requisites and permissions required for holding protests, demonstrations, to address the issue of mob violence. “In the absence of any law on the subject, the Hon’ble Supreme Court has also issued guidelines under Article 142 of the Constitution of India. The decisions reported in 2020 SCC Online SC 355 and in (2018) 10 SCC 713 are binding on all, including political parties and associations,” the bench said. Holding thus the court asked the Addl. Advocate General to get instructions as to the action taken against those persons, who have violated the provisions of the Disaster Management Act, 2005, and the Kerala Epidemic Diseases Ordinance, 2020. The bench however refrained from making any direction for “de-recognition” of political parties as it observed that there is no legislation/ provision issued by the Election Commission of India or the Central Government permitting the same. Case Details: Case No.: WP (C) No. 14141/2020 Quorum: Chief Justice S Manikumar and Justice Shaji P Caly Appearance: Advocate Dr. KP Pradeep (for Petitioner); AGA Ranjith Thampan (for State) Click Here To Download Order Read Order Subscribe to LiveLaw, enjoy Ad free version and other unlimited features, just INR 599 Click here to Subscribe. All payment options available.loading….Next Storylast_img read more

Activist Faisal Khan, Arrested For Offering Namaz At Mathura Temple Granted Bail By Allahabad High Court

first_imgNews UpdatesActivist Faisal Khan, Arrested For Offering Namaz At Mathura Temple Granted Bail By Allahabad High Court Sparsh Upadhyay20 Dec 2020 12:15 AMShare This – x”Didn’t enter into the sanctum sanctorum of Temple, performed Namaz with the permission of priest of Temple”, Khan argued.Peace Activist Faisal Khan, who was arrested for offering Namaz inside the premises of the Nand Baba temple in Mathura (Uttar Pradesh) has been granted bail by the Allahabad High Court on Friday (18th December). The Bench of Justice Siddharth gave this order while hearing the bail application of Faisal Khan praying that he be release on bail in Case Crime No. 390 of 2020, under…Your free access to Live Law has expiredTo read the article, get a premium account.Your Subscription Supports Independent JournalismSubscription starts from ₹ 599+GST (For 6 Months)View PlansPremium account gives you:Unlimited access to Live Law Archives, Weekly/Monthly Digest, Exclusive Notifications, Comments.Reading experience of Ad Free Version, Petition Copies, Judgement/Order Copies.Subscribe NowAlready a subscriber?LoginPeace Activist Faisal Khan, who was arrested for offering Namaz inside the premises of the Nand Baba temple in Mathura (Uttar Pradesh) has been granted bail by the Allahabad High Court on Friday (18th December). The Bench of Justice Siddharth gave this order while hearing the bail application of Faisal Khan praying that he be release on bail in Case Crime No. 390 of 2020, under Sections 153- A, 295, 505, 419, 420, 467, 468, 471 IPC, Police Station Barsana, District- Mathura during pendency of trial. Background As averred by the Bail Applicant, the incident is of Thursday (29th October) while applicant was concluding his four day bicycle rally “Brij 84 Kosi Parikrama” aimed at spreading the message of inter-faith dialogue , love, empathy and religious tolerance. On that day, he visited Nandbaba Temple and engaged in interfaith dialogue with the priest of Nandbaba Temple and other devotees inside the temple. A video recording of the said incident was recorded and uploaded on Facebook by one Goswami Shubham Kant Ji (associated with running the temple). He also offered Namaz in the backyard of Nand Baba Mandir as a gesture of communal harmony as he wanted to spread the message of peace. Khan has further averred in his bail application that the head of the Temple requested applicant to offer Namaz within the Temple as it was time to offer Namaz and the Masjid was at a distance. On the other hand, as per the FIR, allegation against him is that he, along with co-accused, Chand Mohammad performed Namaz inside the temple without consent of priest and its photographs were made it viral. The news was shown on the television. Thereafter, a first information report was lodged on the allegation that this act of the applicant and co-accused shows disrespect for the religious feeling of other community and there is possibility of deterioration in the communal harmony. It has also been suspected that the applicants are receiving foreign funds. Bail application rejected by the Courts below The Applicant, Faisal khan earlier moved Magistrate Court, Chhata Tehsil on Tuesday (03rd November), however, his bai application was rejected. Thereafter, he approached ADJ-02, Mathura District Court. However, this application too, was rejected by the Court vide its order dated Tuesday (24th November) Arguments put forth by the Applicant’s Counsel The counsel for the applicant submitted that applicant is a renowned social activist who has revived Khudai Khidmatgar movement of India and is working for maintaining communal harmony for the last 25 years. In this connection, he undertook yatra for visiting temples and that he was offered prasad and lunch by Chief Priest of the temple and he also bestowed blessings on him as clear from photographs in dispute. He further submitted that applicant was falsely implicated in this case. It was also submitted that the FIR was registered with a 3 day delay on Sunday (01st November) and that the ingredients of Sections 153- A, 295, 505, 419, 420, 467, 468, 471 IPC are not met in the present case. He argued that only on the basis of photographs which went viral the applicant cannot be said to have intention to disturb the communal harmony of the society. Further, he said that “He did not enter into the sanctum sanctorum of the temple rather he performed Namaz outside of the temple with the permission of the priest of the temple as clear from the viral photographs. The allegation of receiving foreign funds is without basis.” Court’s Order Having considered the material on record, larger mandate of the Article 21 of the Constitution of India and the Apex Court’s ruling in the case of Dataram Singh Vs. State of U.P. and another, reported in (2018) 3 SCC 22 and without expressing any opinion on the merits of the case, the Court directed, “Let the applicant involved in the aforesaid crime be released on bail on his furnishing a personal bond and two sureties each in the like amount to the satisfaction of the court concerned.” Importantly, he has been asked to not use social media for any such purposes till the conclusion of trial. Senior Advocate Colin Gonsalves assisted by Adv Ali Qambar Zaidi and Adv. Mohd Danish appeared on behalf of the Applicant.Case Title -Faisal Khan v. State of UP [Criminal Misc. Bail application No. – 47754 of 2020] Click Here To Download Bail OrderRead OrderSubscribe to LiveLaw, enjoy Ad free version and other unlimited features, just INR 599 Click here to Subscribe. All payment options available.loading….Next Storylast_img read more